Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2001-09-13
2010-12-21
Pak, Michael (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07855269
ABSTRACT:
A method for treating down-regulating IL-19 or mda7 by administering the soluble IL-20RA/IL-20R heterodimeric receptor.
REFERENCES:
patent: 5723299 (1998-03-01), Bell et al.
patent: 5789192 (1998-08-01), Moore et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5945511 (1999-08-01), Lok et al.
patent: 5985614 (1999-11-01), Rosen et al.
patent: 6020163 (2000-02-01), Conklin
patent: 6486301 (2002-11-01), Ebner et al.
patent: 6576743 (2003-06-01), Conklin et al.
patent: 6610286 (2003-08-01), Thompson et al.
patent: 2002/0042366 (2002-04-01), Thompson et al.
patent: WO94/013801 (1994-06-01), None
patent: WO99/003982 (1999-01-01), None
patent: WO99/007740 (1999-02-01), None
patent: WO99/007848 (1999-02-01), None
patent: WO99/027103 (1999-06-01), None
patent: WO99/037772 (1999-07-01), None
patent: WO99/046281 (1999-09-01), None
patent: WO99/046379 (1999-09-01), None
patent: WO99/061630 (1999-12-01), None
patent: WO00/012708 (2000-03-01), None
patent: WO00/039161 (2000-07-01), None
patent: WO 00/042189 (2000-07-01), None
patent: WO 00/073457 (2000-12-01), None
patent: WO 00/078961 (2000-12-01), None
patent: WO 01/012672 (2001-02-01), None
patent: WO01/46232 (2001-06-01), None
patent: WO 01/046261 (2001-06-01), None
patent: WO 02/012345 (2002-02-01), None
patent: WO 02/058724 (2002-08-01), None
patent: WO 02/070001 (2002-09-01), None
patent: WO 02/072607 (2002-09-01), None
patent: WO 03/039444 (2003-05-01), None
patent: WO 03/051384 (2003-06-01), None
patent: WO2004/085475 (2004-10-01), None
Abbas et al., “Cellular and Molecular Immunology”,4th Ed., pp. 519-520, W.B. Saunders Company, 2000.
Albert et al., “Molecular Biology of the Cell,” 3rdEd., pp. 156-159, Garland Publishing, Inc., 1994.
Asadullah et al.,Arch Dermatol138:1189-1196, 2002.
Asadullah et al.,Pharmacol Rev.55(2):241-269, 2003.
Blumberg et al.,Cell104:9-19, 2001.
Cameron et al., “Cytokines and Chemokines in Autoimmune Disease,” pp. 8-32, Eurekah.com and Klawer Academic/Plenum Publishers, 2003.
Conti et al.,Immunology Letters88:171-174, 2003.
Cunningham et al.,Science244:1081-1085, 1989.
Davis et al.,Cell87:1161-1169, 1996.
De Groot-Kruseman et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-97, Abstract P-2-1, 2002.
Dumoutier et al.,Eur. Cytokin Netw13(2):5-15, 2002.
Dumoutier et al.,J. Immunol.167:3545-3549, 2001.
Dynan et al.,Nature316:774-778; 1985.
Fickenscher et al.,TRENDS in Immunology23(2):89-96,.2002.
George et al., “Macromolecular Sequencing & Synthesis,” pp. 127-149, Ch. 12, Alan R. Liss, Inc., 1988.
Gröne,Veterinary Immunol. and Immunopathal.88:1-12, 2002.
Harlow et al., “Antibodies a Laboratory Manual,” p. 76, Ch. 5, Cold Springs Harbor Laboratory, 1988.
He et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-97, Abstract P-1-23, 2002.
Henikoff et al.,Proc. Nat. Acad. Sci.USA 89:10915-10919, 1992.
Hosoi et al.,The 75thAnnual Meeting, Department of Pharmacology Kumamoto University, p. 89P, Abstract P-112, 2002.
Kotenko,Cytokine&Growth Factor Reviews13:223-240, 2002.
Kotenko et al.,J. Biol. Chem.276(4):2725-2732, 2001.
Kotenko et al.,Oncogone19:2557-2565, 2000.
Kunz et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-97-S-98, Abstract P-2-3, 2002.
Last et al.,J. Investigative Dermatology119(1):325, Abstract 707, 2002.
Liu et al.,Blood100(11):189a-190a, Abstract #710, 2002.
Liu et al.,Journal of Immunology152:1821-1829, 1994.
Liu et al.,Blood102(9):3206-3209, 2003.
Lutfalla et al.,Genomics16:366-373, 1993.
Lutfalla et al.,J. Mol. Evolution41:338-344, 1995.
Lillehoj et al., “Antibody Techniques,” pp. 291-305, Ch. 13, Academic Press, Inc., 1994.
McKinnon et al.,Drug News and Perspectives9(7):389-398, 1996.
Merck Manual 17thEd., pp. 920-925, 1999.
Mohler et al.,FASB J. US Fed of American Soc. For Experimental Biology6(4):A1123, 1992.
Musso et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-98, Abstract P-2-4, 2002.
Ozaki et al.,J. Biol. Chem.277(33):29355-29358, 2002.
Parrish-Novak et al.,J. Biol. Chem.277(49):47517-47523, 2002.
Parrish-Novak et al,J. Interferon&Cytokine Research22(Suppl. 1):S-46, Abstract W-1-5, 2002.
Pirhonen et al.,J. Interferon&Cytokine Research22(Suppl. 1): S-98, Abstract P-2-6, 2002.
Ramesh et. al.,Cancer Gene Therapy:S3, Abstract 008, 2002.
Rich et al.,Curr Biol.11(13):R531-R534, 2001.
Rich,Expert Opin. Ther. Targets7(2):165-174, 2003.
Rohovsky et al., “Growth Factors and Wound Healing” pp. 8-26, Ch. 2, Springer, 1997.
Roitt et al., “Immunology,” 4thEd., pp. 28.10-28.12, Mosby, 1996.
Rose-John,Acta Biochimica Polonica50(3):603-611, 2003.
Salazar et al.,Eur. J. of Clin. Invest.31(12):1070-1077, 2001.
Slavin,J. Immunol. Immunopharmacol17(1):25-29, 1997.
Stolina et al.,J. Interferon&Cytokine Research22(Suppl.1):S-98-S-99, Abstract P-2-7, 2002.
Strengell et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-99, Abstract P-2-8, 2002.
Tachiiri et al.,Genes and Immunity4:153-159, 2003.
Vandenbroeck et al.,J. Biol. Chem.277(28):25668-25676, 2002.
Volk et al.,TRENDS in Immunology22(8):414-417, 2001.
Walter,Immunologic Res.26(1-3):303-308, 2002.
Whitters et al.,J. Interferon&Cytokine Research22(Suppl. 1):S-99-S-100, Abstract P-2-11, 2002.
Witek et al.J. Interferon&Cytokine Research22(Suppl. 1):S-100, Abstract P-2-12, 2002.
Wolk et al.,J. Immunol.168:5397-5402, 2002.
Wuyts et al.,Eur J. Biochem.260:421-429, 1999.
Xie et al.,J. Biol. Chem.275(40):31335-31339, 2000.
Xu et al.,Proc. Nat. Acad. Sci.USA. 98(17):9511-9516 , 2001.
EST from Incyte Pharmaceuticals Inc., INC1429789, 1996.
EST from Incyte Pharmaceuticals Inc., INC1922140, 1996.
EST from Incyte Pharmaceuticals Inc., INC1923851, 1996.
EST from Incyte Pharmaceuticals Inc., INC2119350, 1996.
EST from Incyte Pharmaceuticals Inc., INC2270605, 1996.
EST from Incyte Pharmaceuticals Inc., INC2699058, 1997.
EST from Incyte Pharmaceuticals Inc., INC2701079, 1997.
EST from Incyte Pharmaceuticals Inc., INC2720417, 1997.
EST from Incyte Pharmaceuticals Inc., INC2763478, 1997.
EST from Incyte Pharmaceuticals Inc., INC3256488, 1997.
EST from Incyte Pharmaceuticals Inc., INC3257185, 1997.
EST from Incyte Pharmaceuticals Inc., INC3316826, 1997.
EST from Incyte Pharmaceuticals Inc., INC3376533, 1997.
EST from Incyte Pharmaceuticals Inc., INC357666, 1995.
EST from Incyte Pharmaceuticals Inc., INC4304592, 1998.
EST from Incyte Pharmaceuticals Inc., INC758088, 1996.
EST from Incyte Pharmaceuticals Inc., INC819592, 1996.
EST from Incyte Pharmaceuticals Inc., INC904360, 1996.
EST from TIGR Tentative Human Consensus, THC174656, 1997.
EST from TIGR Tentative Human Consensus, THC197949, 1997.
EST from TIGR Tentative Human Consensus, THC215509, 1997.
GenBank Accession No. AA018585, 1995.
GenBank Accession No. AA018749, 1995.
GenBank Accession No. AA035594, 1995.
GenBank Accession No. AA132964, 1995.
GenBank Accession No. AA134881, 1995.
GenBank Accession No. AA135185, 1995.
GenBank Accession No. AA135300, 1995.
GenBank Accession No. AA299011, 1995.
GenBank Accession No. AA412292, 1997.
GenBank Accession No. AA470014, 1997.
GenBank Accession No. AA494556, 1997.
GenBank Accession No. AA514541, 1997.
GenBank Accession No. AA516435, 1997.
GenBank Accession No. AA528216, 1997.
GenBank Accession No. AA583432, 1997.
GenBank Accession No. AA632915, 1997.
GenBank Accession No. H17201, 1995.
GenBank Accession No. H17978, 1995.
GenBank Accession No. N62509, 1995.
GenBank Accession No. N79409; 1995.
GenBank Accession No. R14678, 1995.
GenBank Accession No. R42401, 1995.
GenBank Accession No. T70354, 1995.
GenBank Accession No. T70439, 1995.
Chandrasekher Yasmin A.
Jaspers Stephen R.
Lunn Paul G.
Pak Michael
Sherbina Nicholas V.
Walker Shelby J.
ZymoGenetics Inc.
LandOfFree
Method for treating inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233390